JP2024510762A5 - - Google Patents

Info

Publication number
JP2024510762A5
JP2024510762A5 JP2023557098A JP2023557098A JP2024510762A5 JP 2024510762 A5 JP2024510762 A5 JP 2024510762A5 JP 2023557098 A JP2023557098 A JP 2023557098A JP 2023557098 A JP2023557098 A JP 2023557098A JP 2024510762 A5 JP2024510762 A5 JP 2024510762A5
Authority
JP
Japan
Prior art keywords
methyl
pyridine
imidazo
ethoxy
sinnoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023557098A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024510762A (ja
JP7833477B2 (ja
Filing date
Publication date
Priority claimed from PCT/CN2021/081254 external-priority patent/WO2022193166A1/en
Application filed filed Critical
Publication of JP2024510762A publication Critical patent/JP2024510762A/ja
Publication of JP2024510762A5 publication Critical patent/JP2024510762A5/ja
Application granted granted Critical
Publication of JP7833477B2 publication Critical patent/JP7833477B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023557098A 2021-03-17 2022-03-15 血管拡張性失調症変異(atm)キナーゼの選択的モジュレーターおよびその使用 Active JP7833477B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2021/081254 2021-03-17
PCT/CN2021/081254 WO2022193166A1 (en) 2021-03-17 2021-03-17 Selective modulators of ataxia telangiectasia mutated (atm) kinase and uses thereof
PCT/CN2022/080905 WO2022194138A1 (en) 2021-03-17 2022-03-15 Selective modulators of ataxia telangiectasia mutated (atm) kinase and uses thereof

Publications (3)

Publication Number Publication Date
JP2024510762A JP2024510762A (ja) 2024-03-11
JP2024510762A5 true JP2024510762A5 (cg-RX-API-DMAC7.html) 2025-03-12
JP7833477B2 JP7833477B2 (ja) 2026-03-19

Family

ID=83321678

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023557098A Active JP7833477B2 (ja) 2021-03-17 2022-03-15 血管拡張性失調症変異(atm)キナーゼの選択的モジュレーターおよびその使用

Country Status (8)

Country Link
US (1) US20240207263A1 (cg-RX-API-DMAC7.html)
EP (1) EP4308569A4 (cg-RX-API-DMAC7.html)
JP (1) JP7833477B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230157467A (cg-RX-API-DMAC7.html)
CN (1) CN117412972A (cg-RX-API-DMAC7.html)
AU (1) AU2021433713A1 (cg-RX-API-DMAC7.html)
CA (1) CA3213823A1 (cg-RX-API-DMAC7.html)
WO (2) WO2022193166A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021433713A1 (en) * 2021-03-17 2023-09-28 Suzhou Zanrong Pharma Limited Selective modulators of ataxia telangiectasia mutated (atm) kinase and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
CA2242425C (en) 1996-02-13 2006-07-18 Zeneca Limited Quinazoline derivatives as vegf inhibitors
NZ331191A (en) 1996-03-05 2000-03-27 Zeneca Ltd 4-anilinoquinazoline derivatives and pharmaceutical compositions thereof
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
JP5542832B2 (ja) 2008-10-24 2014-07-09 アイアールエム・リミテッド・ライアビリティ・カンパニー 生合成的に製造したピロリン−カルボキシ−リシンならびにピロリン−カルボキシ−リシンおよびピロリシン基の化学誘導体化を介する部位特異的タンパク質修飾
NO2714752T3 (cg-RX-API-DMAC7.html) 2014-05-08 2018-04-21
GB201516504D0 (en) 2015-09-17 2015-11-04 Astrazeneca Ab Imadazo(4,5-c)quinolin-2-one Compounds and their use in treating cancer
GB201519406D0 (en) 2015-11-03 2015-12-16 Astrazeneca Ab Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
CN111344293A (zh) * 2017-09-20 2020-06-26 阿斯利康(瑞典)有限公司 1,3-二氢咪唑并[4,5-c]噌啉-2-酮化合物及其在治疗癌症中的用途
WO2020052688A1 (en) * 2018-09-14 2020-03-19 Suzhou Zanrong Pharma Limited 1-ISOPROPYL-3-METHYL-8- (PYRIDIN-3-YL) -1, 3-DIHYDRO-2H-IMIDAZO [4, 5-c] CINNOLIN-2-ONE AS SELECTIVE MODULATORS OF ATAXIA TELANGIECTASIA MUTATED (ATM) KINASE AND USES THEREOF
AU2021433713A1 (en) * 2021-03-17 2023-09-28 Suzhou Zanrong Pharma Limited Selective modulators of ataxia telangiectasia mutated (atm) kinase and uses thereof

Similar Documents

Publication Publication Date Title
JP7461390B2 (ja) メニン-mll相互作用の阻害剤
CN112625028B (zh) 用于抑制shp2活性的化合物和组合物
CN110325533B (zh) Menin-mll相互作用的抑制剂
US11046699B2 (en) Pyrazolo-pyrimidin-amino-cycloalkyl compounds and their therapeutic uses
US10308660B2 (en) Compounds and compositions for inhibiting the activity of SHP2
JP6242885B2 (ja) 5−アザインダゾール化合物及び使用方法
AU2019381808A1 (en) ERK inhibitors and uses thereof
CA2984259A1 (en) Combinations of inhibitors of irak4 with inhibitors of btk
JP2023545274A (ja) 癌を処置する化合物および方法
JP2011500806A5 (cg-RX-API-DMAC7.html)
US10526311B2 (en) Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
TW200811159A (en) Therapeutic compounds
JPWO2021060453A5 (cg-RX-API-DMAC7.html)
JP2022500428A5 (cg-RX-API-DMAC7.html)
JP2013523814A5 (cg-RX-API-DMAC7.html)
JP2023505878A (ja) インターフェロン遺伝子刺激因子(sting)のモジュレーターとしての複素環式化合物
TW202341982A (zh) Cdk2抑制劑及其用途
JPWO2019216294A5 (cg-RX-API-DMAC7.html)
TW202525797A (zh) 作為menin-mll交互作用之抑制劑的芳基醚類似物
WO2019197269A1 (en) Combinations of copanlisib with triazolone derivatives and their use in the treatment of cancer
JP2011522849A5 (cg-RX-API-DMAC7.html)
EP4301371A1 (en) Substituted 3,6-dihydro-2h-1,3,4-oxadiazin-2-ones for the treatment of sarcoma
TW202600142A (zh) Her2抑制劑的劑量與治療方案
CN113563244A (zh) 取代的氮杂五元环类化合物及其在药物中的应用
US20210369724A1 (en) Combination of atr kinase inhibitors with 2,3-dihydroimidazo[1,2-c]quinazoline compounds